Theravance Biopharma Inc. (TBPH)
NASDAQ · Healthcare
Theravance Biopharma Inc. Cash on Hand 2012–2025
Theravance Biopharma Inc. annual cash on hand history from 2014 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Theravance Biopharma Inc. cash on hand as of December 31, 2025: 167.8M, a 343.97% increase year-over-year.
- Theravance Biopharma Inc. cash on hand for 2025 were 167.8M, a 343.97% increase from 2024.
- Theravance Biopharma Inc. cash on hand for 2024 were 37.8M, a 4.42% decrease from 2023.
- Theravance Biopharma Inc. cash on hand for 2023 were 39.5M, a 86.74% decrease from 2022.
- Theravance Biopharma Inc. cash on hand for 2022 were 298.2M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Theravance Biopharma Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $168 |
| 2024 | $38 |
| 2023 | $40 |
| 2022 | $298 |
| 2021 | $90 |
| 2020 | $81 |
| 2019 | $58 |
| 2018 | $378 |
| 2017 | $89 |
| 2016 | $345 |
| 2015 | $113 |
| 2014 | $89 |
Theravance Biopharma Inc. Cash on Hand — FAQ
Theravance Biopharma Inc. (TBPH) cash on hand over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TBPH's cash on hand history?
The chart and table above show Theravance Biopharma Inc.'s cash on hand by year and by quarter, including the growth rate.